135 related articles for article (PubMed ID: 3515764)
21. [Estimation of activity of bis-netropsin derivatives based on a model of an experimental cutaneous herpes simplex virus disease of guinea pigs].
andronova VL; Grokhovskiĭ SL; Surovaia AN; Gurskiĭ GV; Deriabin PG; L'vov DK; Galegov GA
Vopr Virusol; 2013; 58(1):32-5. PubMed ID: 23785759
[TBL] [Abstract][Full Text] [Related]
22. Acyclovir and other chemotherapy for herpes group viral infections.
Balfour HH
Annu Rev Med; 1984; 35():279-91. PubMed ID: 6326661
[TBL] [Abstract][Full Text] [Related]
23. Betadine for herpes simplex infection.
Waters LJ; Barton SE; Boag FC
Int J STD AIDS; 2006 Dec; 17(12):854-5. PubMed ID: 17212866
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of therapeutic activity of idoxuridine and acyclovir in experimentally-induced herpetic keratitis in rabbits (author's transl)].
Colin C; Chastel C; Quillien MC; Renard G
J Fr Ophtalmol; 1981; 4(1):33-43. PubMed ID: 7217623
[TBL] [Abstract][Full Text] [Related]
25. Testing of the in vivo therapeutic efficacy on the cutaneous herpes simplex infections of the autochthonous product 5% Acyclovir ointment.
Crişan I; Rojanschi D; Petica M; Fodor C; Morar S; Muţiu A
Rom J Virol; 1996; 47(1-4):13-24. PubMed ID: 9495780
[TBL] [Abstract][Full Text] [Related]
26. Acyclovir--a promising antiviral agent: a review of the preclinical and clinical data in ocular herpes simplex management.
Koliopoulos J
Ann Ophthalmol; 1984 Jan; 16(1):19-24. PubMed ID: 6322661
[TBL] [Abstract][Full Text] [Related]
27. New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease.
Kleymann G; Fischer R; Betz UA; Hendrix M; Bender W; Schneider U; Handke G; Eckenberg P; Hewlett G; Pevzner V; Baumeister J; Weber O; Henninger K; Keldenich J; Jensen A; Kolb J; Bach U; Popp A; Mäben J; Frappa I; Haebich D; Lockhoff O; Rübsamen-Waigmann H
Nat Med; 2002 Apr; 8(4):392-8. PubMed ID: 11927946
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of polyprenyl phosphates in the experimental genital herpes model].
Narovlyansky AN; Ivanova AM; Shevlyagina NV; Didenko LV; Borovaya TG; Izmest'eva AV; Sanin AV; Pronin AV; Ershov FI
Vopr Virusol; 2015; 60(4):9-13. PubMed ID: 26665428
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of bromovinyldeoxyuridine-related compounds in the treatment of experimental herpes simplex keratitis.
Maudgal PC; De Clercq E
Arch Ophthalmol; 1985 Sep; 103(9):1393-7. PubMed ID: 4038133
[TBL] [Abstract][Full Text] [Related]
30. Nucleic acids. 3. Antiviral activity of nucleotides and dinucleoside phosphates containing ara-cytidine.
Renis HE; Hollowell CA; Underwood GE
J Med Chem; 1967 Sep; 10(5):777-82. PubMed ID: 4292736
[No Abstract] [Full Text] [Related]
31. Experimental ocular herpetic infections in rabbits. Treatment with 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine.
Smith KO; Hodges SL; Kennell WL; Galloway KS; Poirier RH; Ogilvie KK; Cheriyan UO
Arch Ophthalmol; 1984 May; 102(5):778-81. PubMed ID: 6326720
[TBL] [Abstract][Full Text] [Related]
32. Infections with herpes simplex viruses (2).
Corey L; Spear PG
N Engl J Med; 1986 Mar; 314(12):749-57. PubMed ID: 3005859
[No Abstract] [Full Text] [Related]
33. Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs.
Park NH; Pavan-Langston D; McLean SL; Lass JH
Arch Dermatol; 1980 Jun; 116(6):672-5. PubMed ID: 7377804
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.
Kern ER; Palmer J; Szczech G; Painter G; Hostetler KY
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):501-13. PubMed ID: 10772730
[TBL] [Abstract][Full Text] [Related]
35. Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit.
Trousdale MD; Dunkel EC; Nesburn AB
Invest Ophthalmol Vis Sci; 1980 Nov; 19(11):1336-41. PubMed ID: 7429768
[TBL] [Abstract][Full Text] [Related]
36. [Effect of L-lysine-A-oxidase on development of herpetic genital infection in guinea pigs].
Smirnova IP; Alekseev SB; Diorditsa SV; Vesa VS; Zaĭtseva IZ
Biull Eksp Biol Med; 1999 Dec; 128(12):654-6. PubMed ID: 10650465
[No Abstract] [Full Text] [Related]
37. Value of the dorsal cutaneous guinea pig model in selecting topical antiviral formulations for the treatment of recurrent herpes simplex type 1 disease.
Poli G; Dall'Ara P; Binda S; Santus G; Poli A; Cocilovo A; Ponti W
Arzneimittelforschung; 2001; 51(5):433-8. PubMed ID: 11413746
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of experimental genital herpes with liposomal interferon].
Mel'nikov VR; Kobrinskiĭ GD; L'vov ND; Bolotin IM; Barinskiĭ IF
Vestn Akad Med Nauk SSSR; 1990; (8):35-7. PubMed ID: 2275275
[TBL] [Abstract][Full Text] [Related]
39. Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases.
Sundmacher R
Metab Pediatr Syst Ophthalmol; 1983; 7(2):89-94. PubMed ID: 6686278
[TBL] [Abstract][Full Text] [Related]
40. Antiviral agents.
Hermans PE; Cockerill FR
Mayo Clin Proc; 1983 Apr; 58(4):217-22. PubMed ID: 6339831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
